Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies | Patent Publication Number 20160095908
US 20160095908 A1Publication DateApr 7, 2016
Original Assignee
Current AssigneeRevance Therapeutics
Inventor/ApplicantsGary E. Borodic
Martin Acquadro
Martin Acquadro
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.